Teva Pharma (NYSE: TEVA) announced that it has sent a letter to Robert J. Coury, Executive Chairman of the Board ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE